THLD Financial Facts

Research and development: 8.08M
Total operating expenses: 10.45M
See Full Income Statement

Deficit accumulated during the development stage: -399.15M
Total assets: 63.96M
See Full Balance Sheet

Threshold Pharmaceuticals, Inc. (THLD) Earnings

  |   Expand Research on THLD
Next EPS Date 3/2/16 *Est. EPS Growth Rate +40.0% *Last Qtr.
Average EPS % Beat Rate -2.9% Revenue Growth Rate 0.0% *Last Qtr.
Average % Move 1-Wk after EPS +0.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/2/15 Q315 -$0.09-$0.14 +$0.05$3.7M$3.69M N/A Details
3/3/15 Q414 -$0.12-$0.13 +$0.01$3.7M$4.1M N/A Details
11/3/14 Q314 -$0.15-$0.12 -$0.03$3.7M$3.82M N/A Details
3/6/14 Q413 -$0.13-$0.10 -$0.03$3.2M$3.58M N/A Details
11/4/13 Q313 $0.02-$0.14 +$0.16$3.2M$3.15M N/A Details
5/2/13 Q113 -$0.16-$0.09 -$0.07$2.9M$2.8M N/A Details
11/2/12 Q312 -$0.06-$0.06 $0.00$1.8M$2.29M N/A Details
5/3/12 Q112 -$2.12N/A N/A N/A$15.65M N/A Details